BioCanRx Funding Opportunity
BioCanRx has set the next intake date for funding applications in its rolling, open call process. BioCanRx builds on past and ongoing investments in the area of cancer biotherapeutics that have…
BioCanRx has set the next intake date for funding applications in its rolling, open call process. BioCanRx builds on past and ongoing investments in the area of cancer biotherapeutics that have…
Here’s a short video to quickly understand the important role of genomics in the human health sector. Each week, our team will present a video on the impact of genomics…
We invite you to read our 2015-2016 Annual Report summarizing our activities. Pleasant reading! Télécharger le document
Genome Canada is pleased to announce the launch of the Genomics Technology Platforms: Operations Support and Technology Development Funds competition. This funding opportunity has two main objectives: Select the…
Researchers from Université Laval’s Infectious Disease Research Centre (IDRC) have made a breakthrough towards the development of a new vaccine against the Zika virus which will be tested for the…
Génome Québec is happy to report that Québec has achieved excellent results in the 5th cycle of the Genomic Applications Partnership Program (GAPP). In total, Québec was awarded two of…
Everyone’s invited to this public event! It’s free, open to all and it concerns you: breast cancer, personalized medicine, patient and doctor roles. A discussion facilitated by Stéphan Bureau, in…
Did you know? Today is DNA Day! April 21 is an important date in the world of scientific research. Indeed, 60 years ago, the DNA structure was discovered by Watson…
Génome Québec welcomes the decision by the Federal Government to grant $237.2 million to Genome Canada Génome Québec is pleased with the decision by Justin Trudeau’s government to grant $237.2…
Génome Québec is pleased to announce a $2 million investment by the Government of Canada. These funds will be used to put in place the GEL3S Network in genomics and…